These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 6450905

  • 21. Acne, hirsutism, and alopecia in adolescent girls. Clinical expressions of androgen excess.
    Rosenfield RL, Lucky AW.
    Endocrinol Metab Clin North Am; 1993 Sep; 22(3):507-32. PubMed ID: 8243445
    [Abstract] [Full Text] [Related]

  • 22. Low-dose glucocorticoids in hyperandrogenism.
    Rizzo L, Dobrovsky V, Danilowicz K, Kral M, Cross G, Serra HA, Bruno OD.
    Medicina (B Aires); 2007 Sep; 67(3):247-52. PubMed ID: 17628912
    [Abstract] [Full Text] [Related]

  • 23. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [Abstract] [Full Text] [Related]

  • 24. Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
    Luboshitzky R, Herer P, Shen-Orr Z.
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):102-7. PubMed ID: 15031776
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.
    Redmond GP, Olson WH, Lippman JS, Kafrissen ME, Jones TM, Jorizzo JL.
    Obstet Gynecol; 1997 Apr; 89(4):615-22. PubMed ID: 9083323
    [Abstract] [Full Text] [Related]

  • 29. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J, Zhu Y, Jiang Y, Cao Y.
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Managing cutaneous manifestations of hyperandrogenic disorders: the role of oral contraceptives.
    Wiegratz I, Kuhl H.
    Treat Endocrinol; 2002 Jul; 1(6):372-86. PubMed ID: 15832490
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Evaluation of plasma testosterone and 5-dihydrotestosterone in hirsutic women using the dexamethasone-HCG-test].
    Haeffele R, Elsaesser F, Haller J, König A.
    Fortschr Androl; 1974 Jul; 3():91-3. PubMed ID: 4469555
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Management of hyperandrogenism in adolescent girls.
    Sultan C, Medlej R, Chevalier C, Lobaccaro JM.
    Horm Res; 1991 Jul; 36(3-4):160-4. PubMed ID: 1840143
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.